Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Molecular Medicine Reports|April 8, 2011
Combined effects of the proteasome inhibitor bortezomib and Hsp70 inhibitors on the B16F10 melanoma cell lineAzmi Yerlikaya, Emrah Okur, Semih Eker, et al.
Regulatory Peptides|September 18, 2012
Activation of vagus nerve by semapimod alters substance P levels and decreases breast cancer metastasisNuray Erin, Ozlem Duymuş, Saffet Oztürk, et al.
Breast Cancer Research and Treatment|February 16, 2015
Autocrine control of MIP-2 secretion from metastatic breast cancer cells is mediated by CXCR2: a mechanism for possible resistance to CXCR2 antagonistsNuray Erin, Esra Nizam, Gamze Tanrıöver, et al.
Experimental and Therapeutic Medicine|February 14, 2018
ADAM proteases involved in inflammation are differentially altered in patients with gastritis or ulcerNuray Erin, Sema Türker, Özlem Elpek, et al.
Pathology Oncology Research : POR|August 27, 2017
Nephronectin is Decreased in Metastatic Breast Carcinoma and Related to Metastatic OrgansSayra Dilmac, Nuray Erin, Necdet Demir, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 16, 2019
HSP90 inhibitor PU-H71 increases radiosensitivity of breast cancer cells metastasized to visceral organs and alters the levels of inflammatory mediatorsŞule Kale, Aylin F Korcum, Ertuğrul Dündar, et al.
International Journal of Molecular Sciences|December 23, 2022
Changes in TRPV1 Expression as Well as Substance P and Vasoactive Intestinal Peptide Levels Are Associated with Recurrence of PterygiumHatice Deniz İlhan, Betül Ünal, Yusuf Ayaz, et al.
World Journal of Gastroenterology|October 13, 2016
Childhood chronic gastritis and duodenitis: Role of altered sensory neuromediatorsAli Islek, Aygen Yilmaz, Gulsum Ozlem Elpek, et al.
Regulatory Peptides|October 22, 2005
Inhibition of substance P activity prevents stress-induced bladder damageFeriha Ercan, Ahmet Akici, Yasemin Ersoy, et al.
Pageof 7